[Table/Fig-3]:
Comparison of clinical, biochemical and microbiological parameters between groups.
Parameter | Groups | N | Mean | SD | p-value | (I) Groups | (J) Groups | Mean Difference (I-J) | p-value |
---|---|---|---|---|---|---|---|---|---|
PI | Group I | 30 | 1.86 | 0.63 | < 0.0001 | Group I | Group II | 0.056 | 1.000 |
Group II | 30 | 1.80 | 0.46 | Group III | 0.825 | < 0.0001 | |||
Group III | 30 | 1.03 | 0.48 | Group II | Group III | 0.769 | < 0.0001 | ||
GI | Group I | 30 | 1.59 | 0.50 | < 0.0001 | Group I | Group II | 0.483 | < 0.0001 |
Group II | 30 | 2.07 | 0.39 | Group III | 1.037 | < 0.0001 | |||
Group III | 30 | 0.55 | 0.29 | Group II | Group III | 1.520 | < 0.0001 | ||
PD | Group I | 30 | 6.70 | 1.12 | < 0.0001 | Group I | Group II | 0.200 | 1.000 |
Group II | 30 | 6.90 | 1.27 | Group III | 3.867 | < 0.0001 | |||
Group III | 30 | 2.83 | 0.75 | Group II | Group III | 4.067 | < 0.0001 | ||
CAL | Group I | 30 | 6.17 | 1.15 | < 0.0001 | Group I | Group II | 0.200 | 1.000 |
Group II | 30 | 6.37 | 1.56 | Group III | 4.700 | < 0.0001 | |||
Group III | 30 | 1.47 | 1.20 | Group II | Group III | 4.900 | < 0.0001 | ||
Pentraxin 3 | Group I | 30 | 3.60 | 1.66 | < 0.0001 | Group I | Group II | 0.503 | 0.523 |
Group II | 30 | 3.09 | 1.82 | Group III | 3.597 | < 0.0001 | |||
Group III | 30 | 0.00 | 0.00 | Group II | Group III | 3.093 | <0.0001 | ||
P.gingivalis (CFU/ml) | Group I | 30 | 2.96 | 1.40 | < 0.0001 | Group I | Group II | 0.51 | 0.166 |
Group II | 30 | 2.45 | 1.07 | Group III | 2.96 | < 0.0001 | |||
Group III | 30 | 0.00 | 0.00 | Group II | Group III | 2.45 | <0.0001 |
Clinical parameters- PI-Plaque index, GI-Gingival index, PD- Probing depth, CAL -Clinical attachment levels.
†SD- Standard deviation; ‡N-Number of patients.
One-way analysis of variance test, followed by Bonferroni’s test